Bicara Therapeutics Ownership | Who Owns Bicara Therapeutics?
Bicara Therapeutics Ownership Summary
Bicara Therapeutics is owned by 27.89% institutional investors, 10.23% insiders, and 61.88% retail investors. Ra capital management is the largest institutional shareholder, holding 13.27% of BCAX shares. T. Rowe Price US Small-Cap Core Equity is the top mutual fund, with 3.33% of its assets in Bicara Therapeutics shares.
BCAX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Bicara Therapeutics | 27.89% | 10.23% | 61.88% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.80% | 11.85% | 52.35% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 7.26M | 13.27% | $144.32M |
| T. rowe price investment management | 6.61M | 12.08% | $131.39M |
| Siren | 5.80M | 10.61% | $115.42M |
| Vestal point capital, lp | 5.42M | 9.92% | $107.90M |
| Deep track capital, lp | 4.06M | 7.43% | $80.80M |
| Janus henderson group | 3.33M | 6.08% | $66.11M |
| Red tree management | 3.17M | 5.80% | $63.06M |
| Tpg gp a | 3.01M | 5.51% | $59.88M |
| Blackrock funding, inc. /de | 2.84M | 5.20% | $56.56M |
| Omega fund management | 2.39M | 4.38% | $47.58M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Red tree management | 3.17M | 56.39% | $63.06M |
| Omega fund management | 2.39M | 29.16% | $47.58M |
| Acorn capital advisors | 643.38K | 3.64% | $12.80M |
| Siren | 5.80M | 3.20% | $115.42M |
| Vestal point capital, lp | 5.42M | 3.02% | $107.90M |
| Superstring capital management lp | 175.90K | 2.74% | $2.78M |
| Aisling capital management lp | 568.92K | 2.38% | $11.32M |
| Dafna capital management | 421.73K | 1.91% | $8.39M |
| Palo alto investors lp | 550.41K | 1.67% | $10.95M |
| Tpg gp a | 3.01M | 1.63% | $59.88M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| T. rowe price investment management | 6.61M | 0.09% | 3.37M |
| Vestal point capital, lp | 5.42M | 3.02% | 1.85M |
| Deep track capital, lp | 4.06M | 1.32% | 1.45M |
| Healthinvest partners ab | 1.17M | 0.75% | 1.06M |
| Citadel advisors | 1.66M | 0.01% | 887.08K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Braidwell lp | - | - | -2.16M |
| Deerfield management company, l.p. (series c) | - | - | -1.80M |
| Wellington management group llp | - | - | -1.39M |
| Fmr | 2.10M | 0.00% | -1.25M |
| Adage capital partners gp | - | - | -1.18M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Candriam s.c.a. | 238.82K | 0.02% | 238.82K | $4.75M |
| Vanguard fiduciary trust | 216.75K | 0.00% | 216.75K | $4.31M |
| Walleye capital | 108.01K | 0.01% | 108.01K | $2.15M |
| Burkehill global management, lp | 100.00K | 0.10% | 100.00K | $1.99M |
| Cantor fitzgerald, l. p. | 100.00K | 0.01% | 100.00K | $1.58M |
Sold Out
| Holder | Change |
|---|---|
| Aster capital management (difc) | -1.00 |
| Sbi securities | -1.00 |
| Mrp capital investments | -20.00 |
| Bellevue asset management | -61.00 |
| Signaturefd | -80.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 78 | -45.83% | 15,246,758 | -73.87% | 27 | 0.24% | 48 | -46.67% | 17 | -51.43% |
| Dec 31, 2025 | 92 | -19.30% | 27,836,301 | -44.55% | 51 | 0.60% | 57 | -12.31% | 23 | -14.81% |
| Sep 30, 2025 | 111 | 5.71% | 49,553,927 | -3.15% | 90 | 1.03% | 64 | -18.99% | 26 | 62.50% |
| Jun 30, 2025 | 105 | 19.32% | 51,165,429 | 15.59% | 93 | 1.42% | 79 | 46.30% | 16 | - |
| Mar 31, 2025 | 92 | 13.58% | 48,567,553 | 4.69% | 89 | 1.23% | 54 | -10.00% | 18 | 157.14% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price US Small-Cap Core Equity | 2.18M | 3.33% | 767.16K |
| T. Rowe Price Small-Cap Stock | 2.18M | 3.33% | 100.70K |
| Vanguard Total Stock Mkt Idx Inv | 1.37M | 2.09% | - |
| T. Rowe Price Instl Small-Cap Stock | 1.20M | 1.82% | 57.85K |
| T. Rowe Price U.S. SC Core Eq Tr-D | 1.03M | 1.58% | 389.76K |
| Fidelity Select Biotechnology | 944.90K | 1.44% | - |
| State Street® SPDR® S&P® Biotech ETF | 779.68K | 1.19% | -5.67K |
| iShares Russell 2000 ETF | 749.71K | 1.14% | 6.30K |
| T. Rowe Price Small-Cap Value | 705.03K | 1.07% | - |
| Franklin Biotechnology Discv A(acc)USD | 665.23K | 1.01% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 21, 2026 | Hyep Ivan | Chief Financial Officer | Sell | $187.88K |
| May 18, 2026 | Mazumdar Claire | Chief Executive Officer | Sell | $239.98K |
| May 18, 2026 | Mazumdar Claire | Chief Executive Officer | Sell | $60.60K |
| May 15, 2026 | Cohlhepp Ryan | President and COO | Sell | $162.34K |
| May 15, 2026 | Cohlhepp Ryan | President and COO | Sell | $91.31K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 10 |
| 2026 Q1 | 2 | 21 |
| 2025 Q4 | - | 23 |
| 2025 Q3 | - | 2 |
| 2025 Q2 | - | 1 |
BCAX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools